Presentation Information
[O33-02]Efficacy and safety of melatonin in infants, children, and adolescents with neurodevelopmental disorders (melmoe study)
○Munetsugu Hara1,2, Yushiro Yamashita2, Koutaro Yuge1,2, Kyoko Hoshino3, Michio Fukumizu3,4 (1.Department of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Fukuoka, 2.Division of Gene Therapy and Regenerative Medicine, Cognitive and Molecular Research Institute of Brain Diseases, Kurume University, Kurume, Fukuoka, 3.Segawa Memorial Neurological Clinic for Children, Chiyoda, Tokyo, 4.Department of Education for Childcare, Faculty of Child Development, Tokyo Kasei University, Sayama, Saitama)